The efficacy and safety of linomide in the treatment of renal cell carcinoma [RCC]. An EORTC phase II study

被引：0
|
作者：
Pawinski, A [1 ]
vanOosterom, AT [1 ]
deMulder, PHM [1 ]
Stoter, G [1 ]
Svedberg, A [1 ]
机构：
[1] EORTC DATA CTR,EORTC GENITOURINARY CANC COOPERAT GRP,BRUSSELS,BELGIUM
来源：
EUROPEAN JOURNAL OF CANCER | 1995年 / 31A卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：461 / 461
页数：1
相关论文
共 50 条
  • [1] An EORTC phase II study of the efficacy and safety of linomide in the treatment of advanced renal cell carcinoma
    Pawinski, A
    vanOosterom, AT
    deWit, R
    Fossa, S
    Croles, J
    Svedberg, A
    Lentz, MA
    deMulder, PHM
    [J]. EUROPEAN JOURNAL OF CANCER, 1997, 33 (03) : 496 - 499
  • [2] EORTC phase II study of daily oral linomide in metastatic renal cell carcinoma patients with good prognostic factors
    deWit, R
    Pawinsky, A
    Stoter, G
    vanOosterom, AT
    Fossa, SD
    Paridaens, R
    Svedberg, A
    deMulder, PHM
    [J]. EUROPEAN JOURNAL OF CANCER, 1997, 33 (03) : 493 - 495
  • [3] Phase II efficacy and safety study of nintedanib versus sunitinib in previously untreated renal cell carcinoma (RCC) patients
    Eisen, Tim
    Shparyk, Yaroslav
    Jones, Robert
    MacLeod, Nicholas James
    Temple, Graham
    Finnigan, Helen
    Kaiser, Rolf
    Studeny, Matus
    Loembe, Arsene Bienvenu
    Bondarenko, Igor
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [4] Safety and clinical efficacy of everolimus in the treatment of advanced renal cell carcinoma (RCC)
    Shahani, Rohan
    Kwan, Kevin G.
    Kapoor, Anil
    [J]. DRUG HEALTHCARE AND PATIENT SAFETY, 2010, 2 : 85 - 91
  • [5] A Phase II Study of Sunitinib in Japanese Patients with Metastatic Renal Cell Carcinoma: Insights into the Treatment, Efficacy and Safety
    Uemura, Hirotsugu
    Shinohara, Nobuo
    Yuasa, Takeshi
    Tomita, Yoshihiko
    Fujimoto, Hiroyuki
    Niwakawa, Masashi
    Mugiya, Soichi
    Miki, Tsuneharu
    Nonomura, Norio
    Takahashi, Masayuki
    Hasegawa, Yoshihiro
    Agata, Naoki
    Houk, Brett
    Naito, Seiji
    Akaza, Hideyuki
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2010, 40 (03) : 194 - 202
  • [6] A phase II study of the efficacy and safety of AMG 102 in patients with metastatic renal cell carcinoma
    Schoffski, Patrick
    Garcia, Jorge A.
    Stadler, Walter M.
    Gil, Thierry
    Jonasch, Eric
    Tagawa, Scott T.
    Smitt, Melanie
    Yang, Xinqun
    Oliner, Kelly S.
    Anderson, Abraham
    Zhu, Min
    Kabbinavar, Fairooz
    [J]. BJU INTERNATIONAL, 2011, 108 (05) : 679 - 686
  • [7] Phase II study of bevacizumab and everolimus (RAD001) in the treatment of advanced renal cell carcinoma (RCC)
    Whorf, R. C.
    Hainsworth, J. D.
    Spigel, D. R.
    Yardley, D. A.
    Burris, H. A., III
    Waterhouse, D. M.
    Vazquez, E. R.
    Greco, F. A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [8] Efficacy and safety of AMG 102 in patients with advanced renal cell carcinoma (RCC)
    Kabbinavar, F.
    Garcia, J. A.
    Stadler, W. M.
    Gil, T.
    Jonasch, E.
    Tagawa, S. T.
    Smitt, M.
    Yang, X.
    Oliner, K.
    Schoffski, P.
    [J]. EJC SUPPLEMENTS, 2009, 7 (02): : 426 - 426
  • [9] Phase II Study of the Safety and Efficacy of Temsirolimus in East Asian Patients with Advanced Renal Cell Carcinoma†
    Sun, Yan
    Rha, Sun
    Lee, Se-Hoon
    Guo, Jun
    Ueda, Takeshi
    Qin, Shukui
    Naito, Seiji
    Cincotta, Maria
    Tokushige, Kota
    Akaza, Hideyuki
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2012, 42 (09) : 836 - 844
  • [10] PHASE I/II STUDY OF DEXNIGULDIPINE AND DOXORUBICINE IN ADVANCED RENAL-CELL CARCINOMA (RCC)
    GEHLING, U
    WEIMAR, C
    SCHULER, U
    RATHGEB, F
    EHNINGER, G
    SCHUMACHER, K
    HAVEMANN, K
    [J]. FASEB JOURNAL, 1995, 9 (03): : A96 - A96
12345